GT Biopharma, Inc.

Q3 2024 13F Holders

Symbol
GTBP
CUSIP
36254L308
Type
Equity
Class
COM
Num filers
17
Total reported value, excl. options
$35.3 M
Manager Report Date Value ($000) Shares Option Type